---

Related Articles:

Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.

2014-11-20

[Int. J. Pharm. 475(1-2) , 191-7, (2014)]

Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL.

2012-03-15

[Cell Cycle 11(6) , 1174-82, (2012)]

Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.

2013-06-15

[J. Neuroimmunol. 259(1-2) , 55-65, (2013)]

Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.

2012-09-01

[J. Pharm. Sci. 101(9) , 3199-213, (2012)]

Impact of antiretroviral pressure on selection of primary human immunodeficiency virus type 1 envelope sequences in vitro.

2013-05-01

[J. Gen. Virol. 94(Pt 5) , 933-43, (2013)]